Ulrich-Vinther M et al. |
Recombinant adeno-associated virus-mediated osteoprotegerin gene therapy inhibits wear debris-induced osteolysis. |
2002 |
J Bone Joint Surg Am |
pmid:12177271
|
Ohmori H et al. |
Linkage and association analyses of the osteoprotegerin gene locus with human osteoporosis. |
2002 |
J. Hum. Genet. |
pmid:12181640
|
Armstrong AP et al. |
A RANK/TRAF6-dependent signal transduction pathway is essential for osteoclast cytoskeletal organization and resorptive function. |
2002 |
J. Biol. Chem. |
pmid:12185073
|
Schoppet M et al. |
RANK ligand and osteoprotegerin: paracrine regulators of bone metabolism and vascular function. |
2002 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:11950689
|
Hasegawa T et al. |
Human periodontal ligament cells derived from deciduous teeth induce osteoclastogenesis in vitro. |
2002 |
Tissue Cell |
pmid:11989970
|
Langdahl BL et al. |
Polymorphisms in the osteoprotegerin gene are associated with osteoporotic fractures. |
2002 |
J. Bone Miner. Res. |
pmid:12096838
|
Zhang J et al. |
Osteoprotegerin abrogates chronic alcohol ingestion-induced bone loss in mice. |
2002 |
J. Bone Miner. Res. |
pmid:12096839
|
Treuheit MJ et al. |
Inverse relationship of protein concentration and aggregation. |
2002 |
Pharm. Res. |
pmid:12033388
|
Lossdörfer S et al. |
Immunohistochemical localization of receptor activator of nuclear factor kappaB (RANK) and its ligand (RANKL) in human deciduous teeth. |
2002 |
Calcif. Tissue Int. |
pmid:12043011
|
Zhang J et al. |
PDGF induces osteoprotegerin expression in vascular smooth muscle cells by multiple signal pathways. |
2002 |
FEBS Lett. |
pmid:12067713
|
Crotti TN et al. |
Receptor activator NF-kappaB ligand (RANKL) expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathy, osteoarthritis, and from normal patients: semiquantitative and quantitative analysis. |
2002 |
Ann. Rheum. Dis. |
pmid:12429533
|
Hofbauer LC and Schoppet M |
Osteoprotegerin deficiency and juvenile Paget's disease. |
2002 |
N. Engl. J. Med. |
pmid:12432053
|
Jono S et al. |
Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. |
2002 |
Circulation |
pmid:12208791
|
Sedger LM et al. |
Characterization of the in vivo function of TNF-alpha-related apoptosis-inducing ligand, TRAIL/Apo2L, using TRAIL/Apo2L gene-deficient mice. |
2002 |
Eur. J. Immunol. |
pmid:12209637
|
Hofbauer LC et al. |
Detection and characterization of RANK ligand and osteoprotegerin in the thyroid gland. |
2002 |
J. Cell. Biochem. |
pmid:12210731
|
Kondo H et al. |
Cyclic adenosine monophosphate/protein kinase A mediates parathyroid hormone/parathyroid hormone-related protein receptor regulation of osteoclastogenesis and expression of RANKL and osteoprotegerin mRNAs by marrow stromal cells. |
2002 |
J. Bone Miner. Res. |
pmid:12211438
|
Theill LE et al. |
RANK-L and RANK: T cells, bone loss, and mammalian evolution. |
2002 |
Annu. Rev. Immunol. |
pmid:11861618
|
Roux S et al. |
RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. |
2002 |
Am. J. Clin. Pathol. |
pmid:11863217
|
Green EA et al. |
Pancreatic lymph node-derived CD4(+)CD25(+) Treg cells: highly potent regulators of diabetes that require TRANCE-RANK signals. |
2002 |
Immunity |
pmid:11869680
|
Kazama JJ et al. |
Circulating osteoprotegerin is not removed through haemodialysis membrane. |
2002 |
Nephrol. Dial. Transplant. |
pmid:12271009
|
Childs LM et al. |
In vivo RANK signaling blockade using the receptor activator of NF-kappaB:Fc effectively prevents and ameliorates wear debris-induced osteolysis via osteoclast depletion without inhibiting osteogenesis. |
2002 |
J. Bone Miner. Res. |
pmid:11811549
|
Holloway WR et al. |
Leptin inhibits osteoclast generation. |
2002 |
J. Bone Miner. Res. |
pmid:11811550
|
Coen G et al. |
Serum osteoprotegerin and renal osteodystrophy. |
2002 |
Nephrol. Dial. Transplant. |
pmid:11812872
|
Woo KM et al. |
Osteoprotegerin is present on the membrane of osteoclasts isolated from mouse long bones. |
2002 |
Exp. Mol. Med. |
pmid:12526098
|
Bengtsson AK and Ryan EJ |
Immune function of the decoy receptor osteoprotegerin. |
2002 |
Crit. Rev. Immunol. |
pmid:12498383
|
Saidenberg Kermanac'h N et al. |
Osteoprotegerin and inflammation. |
2002 Apr-Jun |
Eur. Cytokine Netw. |
pmid:12101070
|
Jung K et al. |
Osteoprotegerin and receptor activator of nuclear factor-kappaB ligand (RANKL) in the serum of healthy adults. |
2002 Jul-Sep |
Int. J. Biol. Markers |
pmid:12408468
|
Younes A and Aggarwall BB |
Clinical implications of the tumor necrosis factor family in benign and malignant hematologic disorders. |
2003 |
Cancer |
pmid:12879461
|
Liu JZ et al. |
[Expression of human osteoprotegerin gene in E. Coli and bioactivity analysis of expression product]. |
2003 |
Zhonghua Wai Ke Za Zhi |
pmid:14680558
|
Nawroth P et al. |
[Osteoporosis and cardiovascular disease--two sides of the same coin?]. |
2003 |
Med. Klin. (Munich) |
pmid:12928809
|
Yamada Y et al. |
Association of polymorphisms of the osteoprotegerin gene with bone mineral density in Japanese women but not men. |
2003 |
Mol. Genet. Metab. |
pmid:14680982
|
Nakatsuka K et al. |
Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene. |
2003 |
J. Bone Miner. Res. |
pmid:12929927
|
Li JP and Ling JQ |
[Tumor necrosis factor and lipopolysaccharide affect periodontal ligament cells expressing osteoprotegerin in vitro]. |
2003 |
Zhonghua Kou Qiang Yi Xue Za Zhi |
pmid:12930661
|
Schett G et al. |
The role of osteoprotegerin in arthritis. |
2003 |
Arthritis Res. Ther. |
pmid:12932284
|
Stilgren LS et al. |
Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism. |
2003 |
Calcif. Tissue Int. |
pmid:14667132
|
Karsdal MA et al. |
Transforming growth factor-beta controls human osteoclastogenesis through the p38 MAPK and regulation of RANK expression. |
2003 |
J. Biol. Chem. |
pmid:12933809
|
Okada T et al. |
Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. |
2003 |
Clin. Exp. Metastasis |
pmid:14669795
|
Benevolenskaia LI |
[Issues of osteoporosis in present-day medicine]. |
2003 |
Vestn. Akad. Med. Nauk SSSR |
pmid:12934464
|
Sugatani T et al. |
Activin A stimulates IkappaB-alpha/NFkappaB and RANK expression for osteoclast differentiation, but not AKT survival pathway in osteoclast precursors. |
2003 |
J. Cell. Biochem. |
pmid:12938156
|
Min JK et al. |
Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand. |
2003 |
J. Biol. Chem. |
pmid:12893832
|
Teitelbaum SL and Ross FP |
Genetic regulation of osteoclast development and function. |
2003 |
Nat. Rev. Genet. |
pmid:12897775
|
Hayashi S et al. |
Distinct osteoclast precursors in the bone marrow and extramedullary organs characterized by responsiveness to Toll-like receptor ligands and TNF-alpha. |
2003 |
J. Immunol. |
pmid:14607912
|
Padigel UM et al. |
TRANCE-RANK costimulation is required for IL-12 production and the initiation of a Th1-type response to Leishmania major infection in CD40L-deficient mice. |
2003 |
J. Immunol. |
pmid:14607948
|
Gruber HE and Rude RK |
Alterations in osteoclast morphology following osteoprotegerin administration in the magnesium-deficient mouse. |
2003 |
Biotech Histochem |
pmid:14989640
|
Terpos E et al. |
New insights into the pathophysiology and management of bone disease in multiple myeloma. |
2003 |
Br. J. Haematol. |
pmid:14632767
|
Ha H et al. |
Lipid rafts are important for the association of RANK and TRAF6. |
2003 |
Exp. Mol. Med. |
pmid:14508068
|
Zhang L et al. |
The role of calmodulin in the regulation of osteoclastogenesis. |
2003 |
Endocrinology |
pmid:12960067
|
Yamada T et al. |
Regulation of osteoclast development by Notch signaling directed to osteoclast precursors and through stromal cells. |
2003 |
Blood |
pmid:12411305
|
Boyan BD et al. |
Osteoblasts generate an osteogenic microenvironment when grown on surfaces with rough microtopographies. |
2003 |
Eur Cell Mater |
pmid:14577052
|
Zhang J et al. |
Soluble receptor activator of nuclear factor kappaB Fc diminishes prostate cancer progression in bone. |
2003 |
Cancer Res. |
pmid:14633717
|
Chan BY et al. |
Effect of anticoagulants and storage temperature on the stability of receptor activator for nuclear factor-kappa B ligand and osteoprotegerin in plasma and serum. |
2003 |
Clin. Chem. |
pmid:14633883
|
Jung K et al. |
Serum osteoprotegerin and receptor activator of nuclear factor-kappa B ligand as indicators of disturbed osteoclastogenesis in patients with prostate cancer. |
2003 |
J. Urol. |
pmid:14634401
|
Su X et al. |
[The effects of 17 beta-estradiol on the expression of osteoprotegerin, the ligand of osteoprotegerin and related cytokines in osteosarcoma MG63 cells]. |
2003 |
Zhonghua Nei Ke Za Zhi |
pmid:14636471
|
Takayanagi H |
[Crosstalk between the immune and skeletal system]. |
2003 |
Ryumachi |
pmid:14598653
|
Cho TJ et al. |
Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. |
2003 |
Arthritis Rheum. |
pmid:14558090
|
von Tirpitz C et al. |
Effect of systemic glucocorticoid therapy on bone metabolism and the osteoprotegerin system in patients with active Crohn's disease. |
2003 |
Eur J Gastroenterol Hepatol |
pmid:14560148
|
Barillé-Nion S and Bataille R |
New insights in myeloma-induced osteolysis. |
2003 |
Leuk. Lymphoma |
pmid:14565645
|
Mandelin J et al. |
Imbalance of RANKL/RANK/OPG system in interface tissue in loosening of total hip replacement. |
2003 |
J Bone Joint Surg Br |
pmid:14653607
|
Malyszko J et al. |
Osteoprotegerin and its correlations with new markers of bone formation and bone resorption in kidney transplant recipients. |
2003 |
Transplant. Proc. |
pmid:14529897
|
Bord S et al. |
The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. |
2003 |
Bone |
pmid:12633785
|
Garber K |
Why it hurts: researchers seek mechanisms of cancer pain. |
2003 |
J. Natl. Cancer Inst. |
pmid:12783923
|
Liu B et al. |
Multinucleated giant cells in various forms of giant cell containing lesions of the jaws express features of osteoclasts. |
2003 |
J. Oral Pathol. Med. |
pmid:12787044
|
Eaton CL and Coleman RE |
Pathophysiology of bone metastases from prostate cancer and the role of bisphosphonates in treatment. |
2003 |
Cancer Treat. Rev. |
pmid:12787713
|
Fahrleitner-Pammer A et al. |
Osteoprotegerin serum levels in women: correlation with age, bone mass, bone turnover and fracture status. |
2003 |
Wien. Klin. Wochenschr. |
pmid:12793029
|
Dovio A et al. |
Correspondence re: A. Lipton et al., Serum osteoprotegerin levels in healthy controls and cancer patients. Clin. Cancer Res., 8: 2306-2310, 2002. |
2003 |
Clin. Cancer Res. |
pmid:12796409
|
Flick LM et al. |
Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing. |
2003 |
J. Orthop. Res. |
pmid:12798068
|
Khapli SM et al. |
IL-3 acts directly on osteoclast precursors and irreversibly inhibits receptor activator of NF-kappa B ligand-induced osteoclast differentiation by diverting the cells to macrophage lineage. |
2003 |
J. Immunol. |
pmid:12816992
|
Kawase Y et al. |
Bone malformations in interleukin-18 transgenic mice. |
2003 |
J. Bone Miner. Res. |
pmid:12817749
|
Kikuchi T et al. |
Cot/Tpl2 is essential for RANKL induction by lipid A in osteoblasts. |
2003 |
J. Dent. Res. |
pmid:12821717
|
D'Elia HF et al. |
Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor 1. |
2003 |
Arthritis Res. Ther. |
pmid:12823855
|
Cheung J et al. |
Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene. |
2003 |
J. Endocrinol. |
pmid:12773123
|
Nakamura H et al. |
Suppression of osteoblastic phenotypes and modulation of pro- and anti-apoptotic features in normal human osteoblastic cells under a vector-averaged gravity condition. |
2003 |
J. Med. Dent. Sci. |
pmid:12968638
|
Viereck V et al. |
Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. |
2003 |
J. Clin. Endocrinol. Metab. |
pmid:12970288
|
Yamagami H et al. |
Inhibition of osteoclastogenesis by a phosphodiesterase 4 inhibitor XT-611 through synergistic action with endogenous prostaglandin E2. |
2003 |
Biochem. Pharmacol. |
pmid:12948861
|
Srivastava S et al. |
Receptor activator of NF-kappaB ligand induction via Jak2 and Stat5a in mammary epithelial cells. |
2003 |
J. Biol. Chem. |
pmid:12952963
|
Lee HA et al. |
Bumetanide, the specific inhibitor of Na+-K+-2Cl- cotransport, inhibits 1alpha,25-dihydroxyvitamin D3-induced osteoclastogenesis in a mouse co-culture system. |
2003 |
Exp. Physiol. |
pmid:12955156
|
Yorke R et al. |
Receptor activator of nuclear factor kappaB (RANK) is expressed as a late event during malignant progression in Barrett's metaplasia. |
2003 |
Eur. J. Cancer |
pmid:12957466
|
Kaneyama K et al. |
Expression of osteoprotegerin in synovial tissue and degradation of articular cartilage: comparison with arthroscopic findings of temporomandibular joint disorders. |
2003 |
Oral Surg Oral Med Oral Pathol Oral Radiol Endod |
pmid:12973279
|
Wong T et al. |
Therapeutic implications for interferon-alpha in arthritis: a pilot study. |
2003 |
J. Rheumatol. |
pmid:12734885
|
Al-Qawasmi RA et al. |
Genetic predisposition to external apical root resorption in orthodontic patients: linkage of chromosome-18 marker. |
2003 |
J. Dent. Res. |
pmid:12709501
|
Fujita D et al. |
Prostaglandin E2 induced the differentiation of osteoclasts in mouse osteoblast-depleted bone marrow cells. |
2003 |
Prostaglandins Leukot. Essent. Fatty Acids |
pmid:12711253
|
Katavić V et al. |
Increased bone mass is a part of the generalized lymphoproliferative disorder phenotype in the mouse. |
2003 |
J. Immunol. |
pmid:12538719
|
Clohisy D |
Cellular mechanisms of osteolysis. |
2003 |
J Bone Joint Surg Am |
pmid:12540662
|
Vanderkerken K et al. |
Recombinant osteoprotegerin decreases tumor burden and increases survival in a murine model of multiple myeloma. |
2003 |
Cancer Res. |
pmid:12543775
|
Yu Q et al. |
Cooperation of TNF family members CD40 ligand, receptor activator of NF-kappa B ligand, and TNF-alpha in the activation of dendritic cells and the expansion of viral specific CD8+ T cell memory responses in HIV-1-infected and HIV-1-uninfected individuals. |
2003 |
J. Immunol. |
pmid:12574344
|
Rifas L et al. |
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts. |
2003 |
J. Cell. Biochem. |
pmid:12577299
|
Gordeladze JO and Reseland JE |
A unified model for the action of leptin on bone turnover. |
2003 |
J. Cell. Biochem. |
pmid:12577304
|
Lubberts E et al. |
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. |
2003 |
J. Immunol. |
pmid:12594294
|
Toraldo G et al. |
IL-7 induces bone loss in vivo by induction of receptor activator of nuclear factor kappa B ligand and tumor necrosis factor alpha from T cells. |
2003 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:12490655
|
Nishimura K et al. |
Effects of irradiation on cementum matrix cytokins function during periodontal regeneration. |
2003 |
Hum. Cell |
pmid:15147042
|
Choi BK et al. |
Induction of osteoclastogenesis and matrix metalloproteinase expression by the lipooligosaccharide of Treponema denticola. |
2003 |
Infect. Immun. |
pmid:12496170
|
Liu D et al. |
Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction. |
2003 |
Int. J. Mol. Med. |
pmid:12469211
|
Chagraoui H et al. |
Stimulation of osteoprotegerin production is responsible for osteosclerosis in mice overexpressing TPO. |
2003 |
Blood |
pmid:12506018
|
Lee Y et al. |
Differences in the cytokine profiles associated with prostate cancer cell induced osteoblastic and osteolytic lesions in bone. |
2003 |
J. Orthop. Res. |
pmid:12507581
|
Sabokbar A et al. |
Two distinct cellular mechanisms of osteoclast formation and bone resorption in periprosthetic osteolysis. |
2003 |
J. Orthop. Res. |
pmid:12507582
|
Elhasid R et al. |
Familial severe congenital neutropenia associated with infantile osteoporosis: a new entity. |
2003 |
Am. J. Hematol. |
pmid:12508266
|
Haynes DR et al. |
Osteoprotegerin expression in synovial tissue from patients with rheumatoid arthritis, spondyloarthropathies and osteoarthritis and normal controls. |
2003 |
Rheumatology (Oxford) |
pmid:12509625
|
Crotti TN et al. |
Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. |
2003 |
J. Rheumatol. |
pmid:14677171
|
Sasaki T |
Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption. |
2003 |
Microsc. Res. Tech. |
pmid:12879416
|
Helfrich MH |
Osteoclast diseases. |
2003 |
Microsc. Res. Tech. |
pmid:12879419
|